Llwytho...
Cholangiocarcinoma: novel therapeutic targets
INTRODUCTION: Cholangiocarcinoma (CCA) is a liver cancer derived from the biliary tree with a less than 30% five-year survival rate. Early diagnosis of CCA is challenging and treatment options are limited. Some CCA patients have genetic mutations and several therapeutic drugs or antibodies have been...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Expert Opin Ther Targets |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7129482/ https://ncbi.nlm.nih.gov/pubmed/32077341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14728222.2020.1733528 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|